The balance of available evidence supports its useBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6985.1005a (Published 15 April 1995) Cite this as: BMJ 1995;310:1005
- Simon P Harding
- Consultant ophthalmic surgeon Royal Liverpool University Hospital, Liverpool L7 8XP
EDITOR,—J I McGill and J E White's paper adds further to the debate on the efficacy of oral acyclovir in herpes zoster ophthalmicus.1 It reports the long term follow up of a small sample of patients with ophthalmic complications from a study of 205 patients with herpes zoster in any dermatome.2 Pain and ocular complications were significantly less frequent at six months and five years. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial